Your browser doesn't support javascript.
loading
Further studies to evaluate methods of leucoreduction to prevent alloimmune platelet refractoriness and induce tolerance in a dog platelet transfusion model.
Slichter, S J; Abrams, K; Bailey, S Lawrence; Pellham, E; Gettinger, I; Christoffel, T; Gaur, L; Latchman, Y; Nelson, K; Bolgiano, D.
Afiliação
  • Slichter SJ; Research Institute, Bloodworks Northwest, Seattle, WA, USA.
  • Abrams K; University of Washington School of Medicine, Seattle, WA, USA.
  • Bailey SL; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Pellham E; Research Institute, Bloodworks Northwest, Seattle, WA, USA.
  • Gettinger I; Research Institute, Bloodworks Northwest, Seattle, WA, USA.
  • Christoffel T; Research Institute, Bloodworks Northwest, Seattle, WA, USA.
  • Gaur L; Research Institute, Bloodworks Northwest, Seattle, WA, USA.
  • Latchman Y; Ascendant Laboratories, Bellevue, WA, USA.
  • Nelson K; Washington Center for Pain Management, Bellevue, WA, USA.
  • Bolgiano D; Etubics Corporation, Seattle, WA, USA.
Vox Sang ; 111(1): 62-70, 2016 Jul.
Article em En | MEDLINE | ID: mdl-27007858
ABSTRACT

OBJECTIVES:

Three leucoreduction filters were evaluated - when used alone or combined with centrifuge leucoreduction (C-LR) - to prevent alloimmune platelet refractoriness in a dog platelet transfusion model. MATERIALS AND

METHODS:

Donor platelet-rich plasma (PRP) or buffy coat (BC) platelets were either filter leucoreduced (F-LR) or F-LR/C-LR, (51) Cr radiolabelled and transfused. Weekly transfusions were given for up to 8 weeks or until platelet refractoriness. Recipients who accepted treated transfusions were then given non-leucoreduced (non-LR) platelets to determine whether donor-specific tolerance had been induced.

RESULTS:

Acceptance of F-LR PRP transfusions ranged from 29% to 66%. F-LR/C-LR transfusions prepared from PRP were accepted by 92%, from BC by 63% and from pooled PRP by 75% of recipients (p=NS); overall acceptance rate of F-LR/C-LR transfusions was 83%. Tolerance to subsequent non-LR transfusions occurred in 45% of the F-LR-/C-LR-accepting recipients unrelated to DR-B compatibility between donors and recipients (P = 0·18).

CONCLUSION:

In a dog platelet transfusion model, acceptance of donor platelets required combining F-LR with C-LR as apparently each process removes different immunizing WBCs.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Centrifugação / Transfusão de Plaquetas / Filtração / Leucócitos Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Centrifugação / Transfusão de Plaquetas / Filtração / Leucócitos Idioma: En Ano de publicação: 2016 Tipo de documento: Article